ClinicalTrials.gov
public full text
Public Domain
The Effect of Amantadine on Post-COVD-19 Fatigue
This study aimed to investigate amantadine's safety and its effect on reducing post-COVID-19 fatigue.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid#1094736
- Clinical Trial to Assess the Improvement of Fatigue, Sleep Problems, Anxiety / Depression, Neurovegetatives Alterations and Quality of Life After the Administration of ImmunoVita® in Chronic Fatigue Syndrome Patients#837657
- The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms#1124703
- Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis#967600
- Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS Patients#1030197
Record · ID 893828
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive